Vitakey Inc.
Washington, DC
- UEI
- SUPCXTUWSCZ9
- CAGE
- 8P8B5
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 1222 16th St NW, Washington, DC 20036, USA
- Website
- vitakey.com
- Founded
- 2020
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | -$1,603,789 |
| FY2025 | $15,426,816 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Arpa-H - nutrition base satiety modulation | Interior Business Center (DO) | $13,823,027 |
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Medosome Biotec LLC | Bloomington, IN | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Fzata Inc. | Halethorpe, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Unlocked Labs Inc. | Laramie, WY | — |
| Virtici LLC | Seattle, WA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Lumen Bioscience, Inc. | Seattle, WA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Vitakey Inc. is a for-profit corporate entity based in Washington, D.C., specializing in advanced biotechnology and pharmaceutical delivery technologies. The company focuses on developing innovative platform technologies for protecting and delivering therapeutic microbes and proteins, with a particular emphasis on gastrointestinal health applications. Through federal contract and grant awards, Vitakey Inc. provides specialized research and development services in areas such as probiotic stabilization, targeted protein delivery, and advanced encapsulation technologies for medical and nutritional applications.
In its federal contract work, Vitakey Inc. has secured a significant Other Transaction Agreement (OTA) with the National Institutes of Health (NIH) for the ARPA-H Nutrition Base Satiety Modulation program. The contract, valued at $61,465,464.48 and running until November 28, 2028, does not have a specific set-aside designation. The award suggests the company is developing innovative nutritional solutions related to satiety modulation, though specific details about the precise products or services are not fully disclosed in the available documentation.
Vitakey Inc. has been awarded multiple federal grants from different National Institutes of Health agencies, focusing on advanced biotechnology research. These grants include a $349,759 award from the National Institute of Child Health and Human Development to develop a platform encapsulation technology for stabilizing probiotic strains in infant formula, specifically targeting necrotizing enterocolitis prevention in preterm infants. Another grant of $698,074 from the National Institute of Diabetes and Digestive and Kidney Diseases aims to create a platform technology for targeted oral delivery of therapeutic proteins to treat ulcerative colitis. A third grant from the National Institute of General Medical Sciences focused on stabilizing therapeutic microbes for inclusion in enteral feeding liquid matrices, demonstrating the company's expertise in developing advanced drug delivery and stabilization technologies for medical and nutritional applications.
Quick answers
Is Vitakey Inc. registered in SAM.gov?
Yes. Vitakey Inc.'s SAM.gov registration is active through March 4, 2027.
What is Vitakey Inc.'s CAGE code?
Vitakey Inc.'s CAGE code is 8P8B5, and its Unique Entity ID (UEI) is SUPCXTUWSCZ9.
How much has Vitakey Inc. received in federal contracts?
Federal contracts obligated $15,426,816 to Vitakey Inc. in fiscal year 2025 and $13,823,027 in fiscal years 2023 through 2027.
How does Vitakey Inc. rank among federal contractors?
Vitakey Inc. ranked #21 in PSC AN13 and #59 in PSC AN in FY2025.
What is Vitakey Inc.'s most recent federal award?
Vitakey Inc.'s most recent federal grant award is Platform technology for delivery of stabilized therapeutic microbes in powders with high water activity (R43HD117653), from National Institute of Child Health and Human Development (NIH), on June 1, 2025.
On GovTribe
See Vitakey Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors